Advertisement

The Scientist

» business

Most Recent

image: Novartis and Glaxo Agree to Big Deal

Novartis and Glaxo Agree to Big Deal

By | April 22, 2014

The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.

2 Comments

image: The 2014 Salary Survey Is Here

The 2014 Salary Survey Is Here

By | March 10, 2014

Take our survey to help us determine the most current salary data for life scientists.

1 Comment

image: Biotech Superstar Dies

Biotech Superstar Dies

By | March 7, 2014

Alejandro Zaffaroni, who launched companies that developed birth control pills, microarrays, and transdermal drug patches, has died at age 91.  

0 Comments

image: Guidelines for Gene Patent Ruling

Guidelines for Gene Patent Ruling

By | March 7, 2014

The USPTO offers guidance to its patent examiners on how to interpret the Supreme Court’s rulings in the recent Myriad and Prometheus cases.

0 Comments

image: Incubator Boom

Incubator Boom

By | March 1, 2014

From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?  

1 Comment

image: Stem Cell Trials in Peril?

Stem Cell Trials in Peril?

By | January 27, 2014

The only US firm with an ongoing embryonic stem cell therapy clinical trial is in financial and legal hot water.

2 Comments

image: FDA to 23andMe: Stop Marketing Kits

FDA to 23andMe: Stop Marketing Kits

By | November 26, 2013

The US Food and Drug Administration blocks the marketing of unapproved genetic tests.  

9 Comments

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: Geron’s Stem Cell Program Sold

Geron’s Stem Cell Program Sold

By | October 2, 2013

The company, which launched the first ever clinical trial for a human embryonic stem cell therapy before shuttering its stem cell arm, has finally struck a deal with BioTime.

0 Comments

image: Biotech IPOs Surge

Biotech IPOs Surge

By | August 23, 2013

The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
R&D Systems
R&D Systems
Advertisement